In this study, we report the development of the two first ultrasensitive immunoassays specifically measuring p-tau205 and p-tau202, key markers of neuropathological tau in AD, and assess their ability to reflect in vivo neurofibrillary pathology in AD. The gene discussed is MAPT; the disease is Alzheimer disease.